This suggested that ARF5 might participate in the infiltration process of immune cells by promoting the activation of CD4+T cells, promoting immune escape of tumor cells, thereby promoting the progression of HCC and leading to malignant prognosis. The gene discussed is CD4; the disease is hepatocellular carcinoma.